Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
2265
-
Total 13F shares, excl. options
-
1.93B
-
Shares change
-
+7.03M
-
Total reported value, excl. options
-
$162B
-
Value change
-
+$572M
-
Put/Call ratio
-
1.03
-
Number of buys
-
1035
-
Number of sells
-
-997
-
Price
-
$83.85
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q2 2019
2,422 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q2 2019.
Merck & Co., Inc. - Common Stock (MRK) has 2,265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.93B shares
of 2.53B outstanding shares and own 76.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (210M shares), BlackRock Inc. (192M shares), STATE STREET CORP (117M shares), Capital World Investors (84.2M shares), WELLINGTON MANAGEMENT GROUP LLP (55.1M shares), BANK OF AMERICA CORP /DE/ (46.4M shares), JPMORGAN CHASE & CO (40.5M shares), GEODE CAPITAL MANAGEMENT, LLC (38.7M shares), Capital International Investors (36.9M shares), and Bank of New York Mellon Corp (35.7M shares).
This table shows the top 2265 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.